Delivery Order SPE2DB22D1106-SPE2DB24FEFG3
Award Date 3/17/24
Potential Completion Date 3/18/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,286.51, is for the delivery of 4,568,577,972 vials of 800 mg/20 mL Gentamicin, a pharmaceutical product used for treating various bacterial infections. The contract has an ultimate completion date of June 18, 2025 and is not set aside for any specific business type....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on June 26, 2025, for the supply of Gentamicin 800 mg/20 mL vials with a contract value of $1,987.23 and an ultimate completion date of June 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery supporting federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gentamicin 800 mg/20 mL vials totaling $1,791.07. This is a firm fixed-price delivery order under a non-competitive award with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued as a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, for the supply of Gentamicin 800 mg/20 ml vials. This firm fixed-price delivery order, valued at $1,565.55, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $3,704.79 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitively awarded, non-set-aside procurement action. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,381.58 to AmerisourceBergen Drug Corp for the supply of Gentamicin 80 mg/2 ml vials on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used extensively throughout military and federal...
- The Defense Logistics Agency awarded a $10,558.45 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gentamicin pediatric 20 mg/2 mL vials. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a competitively awarded (non-set-aside) procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Gentamicin 800 mg/20 ml vial, a pharmaceutical product, with a ceiling value of $3,974.46. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC provides a...
- The Defense Logistics Agency issued a $3,893.47 delivery order to AmerisourceBergen Drug Corp on February 9, 2026, for Gentamicin 800 mg/20 ml vials. The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2026. This IDC provides pharmaceutical and medical supply support globally to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order has a firm...
- This is a $1,408.05 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4568742299 - GENTAMICIN 2ML 25S, a medical product. The contract is not designated as a set-aside and has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEFG3Delivery Order
This is a firm fixed price delivery order worth $2,234.97, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,988,152 units of the pharmaceutical product Gentamicin 800 mg/20 ml vial. The order has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Generated 6/16/24, 9:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/17/24 |